Protein Dataset: Infrastructure Bottlenecks and Breakthrough Paths in the Era of Protein Intelligence

Preface

Artificial intelligence is profoundly reshaping protein design paradigms. While the industry generally focuses on leaps in algorithm architecture and model capabilities, a more fundamental constraining factor has not received the same level of attention—high-quality protein datasets. Currently, as protein design moves from "proof of concept" to "engineering implementation," the core bottleneck has increasingly shifted to the data side: marginal improvements in model prediction accuracy depend more and more on the scale, diversity, and annotation quality of the training data. This article returns to this foundational proposition, systematically examining the connotation, bottlenecks, and evolution direction of industrial-grade solutions for protein datasets.

01 Definition: The multidimensional composition of protein datasets

Protein dataset

Protein datasets are not simple collections of sequence symbols, but structured, multidimensional digital representations of the protein world. A high-quality protein dataset with engineering value typically includes the following dimensions:

Sequence information: Amino acids are arranged linearly and form the primary language of proteins.

Structural information: 3D folded topology, active site geometry, dynamic conformational system.

Functional tags: Quantitative parameters such as thermal stability (Tm), catalytic efficiency (kcat/km), substrate selectivity, expression level, solubility, etc.

Mutation effect map: Functional changes caused by unit point and combinatorial mutations, serving as the core corpus for AI learning protein sequence-function mapping rules.

Experimental metadata: Parameters such as pH, temperature, and buffer system determine data reproducibility and cross-batch comparability.

The organic integration of these dimensions elevates the dataset from a descriptive file to a causal inference training material. Currently, public databases mainly achieve large-scale accumulation of sequences and structures, but there are still significant gaps in the systematization of functional tags and the traversality of mutation effects.

02 Bottleneck: Structural contradiction between industry-level demand and data supply

The upper bound of AI model capability is defined by the quality ceiling of training data. For industrial applications—such as industrial catalysis, synthetic biology, biomedicine, and other scenarios—public datasets reveal four structural flaws:

First, scarcity and distribution bias of functional labels. Among annotated sequences, the proportion of quantitative functional parameters is extremely low and concentrated in a few model proteins, making it difficult to cover more valuable target categories such as industrial enzymes and membrane proteins.

Second, systematic loss of negative data. Academic publications favored positive results, and a large number of inactivated mutations and unstable variants were not included. The scarcity of negative samples leads to blurred decision boundaries in the model, resulting in a lack of discriminative power when avoiding non-functional sequences.

3. Cross-source noise and incomparability. Functional data obtained under different laboratory and measurement conditions exhibit systematic bias; simple hybrid training introduces conflict signals and weakens the model's generalization ability.

Fourth, dimensional fragmentation. Sequence, structure, and function data belong to independent databases, lacking high-dimensional alignment anchored by "mutation-function," which limits AI's deep learning of protein design rules.

The root of this contradiction lies in the fact that traditional protein datasets tend to accumulate "observational" data, while AI-driven protein engineering requires experimental data that reveals the "intervention-effect" causal relationship. The generation of this data relies on a completely different infrastructure.

03 Breakthrough: Closed-loop dry and wet and the "protein data factory" model

Protein Data Bank

Breaking through data bottlenecks, the industry frontier is shifting from 'mining existing stock' to 'creating incremental value.' The core approach is to build a high-throughput, standardized, dry-and-wet experimental closed-loop data generation system, known as a 'protein data factory.'

The logic lies in this: under precisely controlled experimental conditions, tens of thousands of variants are generated in parallel through an automated platform, and multi-dimensional functional parameters of each variant are uniformly measured, producing context-consistent, fully labeled sequence-function paired data. This model fundamentally addresses the challenges of missing labels, uncontrollable noise, and scarcity of negative samples.

For example, in China, Shanghai Matwings Technology Co., Ltd. independently developed the MatwingsVenus™ (Xiaowu™) platform, which is a typical product of this model. The platform deeply integrates an AI algorithm engine with automated high-throughput wet experimental modules to generate massive private protein datasets with precise experimental labels for specific industrial targets—such as alkali resistance, thermal stability, and catalytic activity. Its operational logic can be summarized as: AI generates sequence candidates → automated experiments measure → data feeds back to train the model → model iterates for optimized design. Every new batch of data comes from real-world physical measurements, fundamentally distinguishing it from purely computational simulations and ensuring that the AI-learned rules are reproducible in engineering practice.

04 Standards: Evaluation Dimensions for Industrial-Grade Protein Datasets

Based on the above practices, industrial-grade protein datasets should follow four evaluation standards:

Multi-dimensional and homologous labels: For the same variant in the same experimental system, simultaneously obtain multi-dimensional labels such as stability, activity, and expression level to eliminate batch bias.

Mutation combination coverage: Includes both single-point and combinatorial mutations to capture epistasis, which is a critical information dimension severely lacking in public datasets.

Balanced positive and negative samples: Systematically design and include inactivated or unstable mutations, enabling the model to have clear discriminative boundaries.

Full process traceability: Each piece of data is accompanied by complete experimental metadata, ensuring alignment between batches and the long-term reliability of accumulated data.

Datasets that meet these standards allow AI models to move from 'co-occurrence-based statistical inference' to 'causal-based engineering prediction,' truly enabling the design of proteins that do not exist in nature on demand.

05 Outlook: Redefining Protein Innovation through Data-Driven Approaches

The Universe of Protein Sequences

The future of protein design is shifting from long laboratory trial-and-error processes to data-driven precision engineering. The core engine of this paradigm shift is the spiral enhancement between the continuous production of high-quality protein datasets and model iteration: data-driven model predictions guide experimental validation, and the validation results feed back as new data points, forming a self-evolving knowledge system.

The protein sequence space is as vast as the universe, making it infeasible to explore purely by computational power. The ultimate variable that determines the boundaries of AI-driven protein design is not the size of the model parameters, but who can first establish a standardized, high-throughput, and reproducible protein dataset production system. The degree of maturity of this infrastructure will directly define the competitive landscape of the next generation of biomanufacturing.